Tender detail
Tocilizumab medicine rebate agreement
Summary
The tender concerns the conclusion of a non-exclusive medicine rebate agreement for medicines containing tocilizumab for the period 01/08/2026–31/07/2028. This is a medicines procurement in which DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The bidder must check the exact conditions in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.